The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab after bevacizumab in platinum-sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213.
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; DOD-CDRMP; Esperance Pharmaceuticals; Genentech/Roche; NCCN
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bayer; Clovis Oncology; Gradalis; Merck; Merrimack; Millennium
 
Mark F. Brady
Consulting or Advisory Role - Aeterna Zentaris; Cel-Sci; Endocyte
 
Thomas J Herzog
No Relationships to Disclose
 
Deborah Kay Armstrong
Consulting or Advisory Role - Eisai (I); Eviti; Morphotek
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (I); Exelixis (I)
Other Relationship - FDA
 
Paul Sabbatini
Research Funding - Bristol-Myers Squibb (Inst); Ludwig Institute for Cancer Research (Inst); OncoMed (Inst)
 
Joan L. Walker
No Relationships to Disclose
 
Byoung Kim
No Relationships to Disclose
 
Keiichi Fujiwara
Honoraria - Chugai Pharma; Eisai; Kyowa Hakko Kirin; Nippon Kayaku; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; MSD; Pfizer
Research Funding - Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Genentech/Roche
 
David M. O'Malley
Consulting or Advisory Role - Eisai; Janssen Oncology
Research Funding - Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Research & Development (Inst); Regeneron (Inst); VentiRx (Inst)